Particle.news

Download on the App Store

Philip Morris Raises 2025 Profit Outlook as Smoke-Free Products Surge

The company reported strong Q1 earnings, driven by growth in ZYN nicotine pouches and IQOS devices, and now forecasts double-digit EPS growth for the year.

Philip Morris lifted its annual guidance, thanks in large part to the growing popularity of Zyn.
A woman poses with a cigarette in front of Philip Morris International logo in this illustration taken July 26, 2022. REUTERS/Dado Ruvic/Illustration
Image
Image

Overview

  • Philip Morris International's Q1 FY25 revenue rose 5.8% year-over-year to $9.30 billion, surpassing analyst estimates of $9.13 billion.
  • Adjusted earnings per share came in at $1.69, exceeding the $1.61 consensus estimate.
  • The smoke-free segment accounted for 42% of total revenue, a 15% increase compared to the same period in 2024, with ZYN U.S. shipment volumes up 53%.
  • The company raised its FY25 adjusted EPS forecast to $7.36–$7.49, up from the previous range of $7.04–$7.17, and projects 6–8% organic revenue growth.
  • Philip Morris shares climbed nearly 4% in premarket trading, reflecting investor confidence in its ongoing transition toward reduced-risk products.